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REST-miR-21-Sox2 axis in mESC pluripotencyOur previous studies have shown that the regulatory network that maintains pluripotency in mouse embryonic
stem cells (mESCs) is regulated in a context-dependent manner and can be modulated, at least in part, by re-
calibration of an intracellular network of pluripotency factors aswell as cues arising from the extracellularmatrix.
The transcriptional repressor REST represses miR-21 and, thus, regulates self-renewal in E14Tg2a.4 mESCs
cultured in the absence of mouse embryonic ﬁbroblast feeder cell effects. However, how miR-21 connects to
the nuclear regulatory network has not been clear. Here, we show that miR-21, a direct target of REST-
mediated repression, directly targets Sox2. Exogenously added miR-21 to mESCs decreases the expression of
Sox2, decreasing mESC self-renewal, and this effect of miR-21 on mESC self-renewal can be blocked by expres-
sion of exogenous Sox2. Conversely, destabilization of Sox2 by miR-21 can be blocked by anti-miR-21. Thus,
the REST–miR-21–Sox2 axis connects REST to the core nuclear pluripotency regulators in E14Tg2a.4 mESCs
cultured in the absence of feeder cells.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The mechanisms by which pluripotency regulators dictate self-
renewal versus differentiation are only recently being studied
(Wagner et al., 2010; Niwa et al., 2009). In addition, various ap-
proaches are being developed to examine such processes (Wang
et al, 2013). The transcriptional repressor REST was discovered as a
major regulator of neuronal genes in non-neural cells, but it is now
known to repress many genes with diverse functions and, thus, to
regulate both normal development and disease states (Ballas and
Mandel, 2005; Kagalwala et al., 2008; Gopalakrishnan, 2009;
Buckley et al., 2010; Gao et al., 2011; Roopra et al., 2012; Hwang
et al., 2013; Negrini et al., 2013). REST is a major chromatin modiﬁer,
and it accomplishes this role by interacting with various cellular co-
factors in a context-dependent manner (Ballas and Mandel, 2005;danderson.org (S. Majumder).
oronto, Toronto, Canada.
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ool, Houston, TX 77030, USA.
. This is an open access article underQureshi et al., 2010; Bithell, 2011; Gao et al., 2012). Its context-
dependent function is also observed in its role in cancer; REST has
an oncogenic function in neural cells, in which it is normally not
expressed, and a tumor suppressor function in non-neural cells, in
which it is normally expressed (Kagalwala et al., 2008). In mESCs,
REST is expressed at very high levels (Ballas et al., 2005) and
genome-wide analysis found it to be a part of the mESC pluripotency
network (Boyer et al., 2005; Johnson et al., 2008; Kim et al., 2008;
Wang et al., 2006). Experimentally, REST was also found to regulate
mESC self-renewal and pluripotency by repressing transcription of
the miR-21 gene, and loss of REST produced expression of differenti-
ation markers (Singh et al., 2008). However, whereas some studies
found that loss of REST did not cause a change in the expression of
differentiation markers (Buckley et al., 2009; Jorgensen et al., 2009;
Jorgensen and Fisher, 2010), others found that loss of REST actually
caused decreased expression of differentiation markers (Yamada
et al., 2010), suggesting a gap in our knowledge of REST-mediated
mESC pluripotency. More recently, it has been shown that this
apparent discrepancy results from the context-dependent function
of REST (Singh et al., 2012). Here we show that, under permissive
conditions, REST–microRNA (miR)-21–Sox2 signaling cascade
maintains self-renewal in E14Tg2a.4 cells.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. mESC cell lines and culture conditions
E14Tg2a.4 mESCs were obtained from Bay Genomics and cultured
without feeder cells in 1000 units ml−1 LIF (ESGRO) on gelatin-coated
tissue culture dishes (Nichols et al., 1990; Singh et al., 2008, 2012).
Embryoid bodies (EB) were grown as non-adherent cultures in the ab-
sence of LIF. In some experiments (EB + LIF), EBs were cultured with
1000 units ml−1 LIF for 18 h.
2.2. Transfection of reporter constructs in mESCs
Approximately, 4 × 106mESCs were nucleofected using AMAXAwith
2 μg of pCAG-HA-Sox2-IP (Addgene) plasmid DNA. Transfected colonies
were then selected for 8 days with 1.5 μg/ml puromycin. These
puromycin-resistant colonies were then used for further experiments.
2.3. Western blotting, pre-miR transfection and miRNA quantiﬁcation
Whole-cell extracts were prepared, and approximately 10–30 μg of
protein was resolved on SDS-PAGE using antibodies against REST
(#07-579, Upstate), Oct4 (#ab19857, Abcam), anti-hemaglutinin (HA)
(H9658, Sigma), Sox2 (#ab15830, Abcam; #2748, Cell Signaling),
β-actin (A5316, Sigma), and α-tubulin (#MMS-407R, Covance).
mESCs were transfected with pre-miR21 (Pre-miR miRNA precursor
molecule; AM17100, Ambion) or control, as described earlier (Singh et al.,
2008). mESCs were transfected using AMAXA nucleofection reagent. Cells
were seeded onto gelatin-coated plates and were harvested at speciﬁc
time points for isolation of total RNA using TRIzol and whole-cell extracts
for Western blot analysis. The miRNA quantiﬁcations were carried
out using total RNA and themirVana (Catalog number AM1560, Life Tech-
nologies) qRT-PCRmiRNA detection kit as per themanufacturer's protocol.
The relative expression levels of individual miRNA were calculated after
normalization with 5S rRNA expression levels.
2.4. Self-renewal assay
An alkaline phosphatase assaywas then performed using an alkaline
phosphatase detection kit (Chemicon) (Singh et al., 2008). Percentages
of self-renewing colonies from three independent experiments were
plotted. Standard error of the mean was calculated and is depicted as
error bars in the ﬁgures.
2.5. Combined in-situ (microRNA)-immunoﬂuorescence (protein)
hybridization
mESCs grown on gelatin coated slideswere ﬁxedwith 4% paraformal-
dehyde for 15min andwashed twice with PBS. The ﬁxed chambers were
incubated in pre-hybridization mix (50% formamide, 1 M NaCl, 1X
denhart, 0.5 mg/ml of Yeast tRNA, and 0.3% Triton X-100) at 57 °C
for 2 h. The ﬁxed cells were hybridized overnight in the presence of
250 nm 5′-biotin conjugated miRCURY locked nucleic acid (LNA)
(Exiqon) at 57 °C. Next, the cells were washed with 5 × SSC for 5 min,
50% formamide in 1 × SSC and 0.1% Tween 20 at hybridization tempera-
ture for 30min, and 0.2 × SSC for 10min, followed by 3washes with PBS.
Cells were incubated in ﬂuorescein–isothiocyanate–avidin (1:500)
(Invitrogen) for 30 min. For the combined immunoﬂuorescence, the
cells were blocked with a biotin–avidin kit (Vector Labs) according to
the manufacturer's recommendations. Cells were blocked with 4%
normal goat serum for 1 h, incubated with primary antibody overnight
at 4 °C, washed with PBS three times, and incubated with corresponding
secondaryAlexa Fluor dyes for 1 h. The cellswere thenwashed twicewith
PBS, mounted with ﬂuorescence mounting media containing DAPI
(Vector Laboratories), and photographed using a Nikon TE2000 camera
controlled with Metamorph software (Molecular Devices).2.6. MicroRNA microarray
Total RNA was isolated using the TRIzol method, and microRNA
microarray analysis was performed as described previously (Singh
et al., 2008).
3. Results
3.1. REST represses miR-21 expression in E14Tg2a.4 mESCs
Non-coding RNAs, including microRNAs, are critical regulators of
biological processes (Gurtan and Sharp, 2013; Gangaraju and Lin,
2009; Ebert and Sharp, 2012; Gao et al., 2012). Previously, we found
that the REST-mediated maintenance of self-renewal and pluripotency
in E14Tg2a.4 cells cultured in the absence of feeder cells occurred by
suppression of miR-21 expression through direct binding of REST to
the miR-21 gene chromatin and subsequent repression of miR-21 tran-
scription (Singh et al., 2008). This observation supports the conclusion
that miR-21 levels are lower in mESCs and higher in EBs, as was previ-
ously observed by others and us (Houbaviy et al., 2003; Singh et al.,
2008) and that miR-21 levels in mESCs increase upon trophectoderm
differentiation (Viswanathan et al., 2009). However, some other reports
found that the level of miR-21 either does not change or is actually
higher in mESCs than in EBs (Buckley et al., 2009). We performed a
genome-wide microRNA expression analysis of E14Tg2a.4 mESC, EB,
and EB + LIF cells (Fig. 1A). The results indicated that under these
conditions, miR-21 expression was indeed low in mESCs and EB + LIF
cells and high in EB cells, reﬂecting the miR-21 status seen by others
and us (Houbaviy et al., 2003; Singh et al., 2008). In addition, expression
of a set of othermicroRNAs, whichwere found to be the direct targets of
REST in E14Tg2a.4mESCs (Singh et al., 2008),was also higher in EBs and
lower in mESCs and EB + LIF cells, as expected.
To further validate this observation, we employed an in situ
(miR-21)-immunoﬂuorescence (REST protein) assay to visualize the
expression patterns of REST and miR-21 in similarly cultured cells
(Fig. 1B). mESCs cultured with LIF (ESCs and EB + LIF cells) showed
high REST and low miR-21 expression patterns, and this pattern was
reversed when the cells were cultured without LIF (EB cells). In a
gain-of-function experiment, we transfected mESCs growing in the
presence of LIF with either a plasmid encoding a neomycin resistance
gene or a plasmid encoding a neomycin resistance gene and Rest, select-
ed the cells as described above, cultured the cells in the absence of LIF,
and subjected them to in situ-immunoﬂuorescence analysis (Fig. 1C).
We found that while the transfection of control plasmid did not alter
the low REST-high miR-21 expression pattern, forced expression of
REST reversed this pattern.
3.2. miR-21 suppresses Sox2 expression
Although bioinformatic analysis indicated that miR-21 had a poten-
tial binding site on Sox2mRNA, themechanism by whichmiR-21 regu-
lates mESC pluripotency remained unknown. To determine if a possible
relationship exists between REST, miR-21, and Sox2, we performed in
situ (miR-21)-immunoﬂuorescence (Sox2) analysis of the cells shown
in Fig. 2A (mESCs cultured with LIF but treated with shREST or control
NT shRNA). As shown in Fig. 2B, shREST-treated cells that were previ-
ously found to show decreased levels of REST protein, as expected,
now showed increased levels of miR-21 and decreased levels of Sox2.
In contrast, non-targeting control-treated cells showed lower miR-21
and higher Sox2 expression levels in mESCs. The REST-mediated axis
of miR-21-Sox2 was also observed in mESCs with transient knock-
down of REST. In-situ-immunoﬂuorescence analysis of cells analyzed
in Fig. 4E showed increased expression ofmiR-21 anddecreased expres-
sion of Sox2 in siRest-treated cells compared to non-targeting control-
treated cells (Supplementary Fig. S1A and B).
Fig. 1. REST represses miR-21 expression in E14Tg2a.4 mESCs. Inverse expression pattern of REST and miR-21. (A) Genome-wide analysis of the REST-repressedmicroRNAs in E14Tg2a.4
mESCs indicated lower expression ofmiR-21 in ES and EB+ LIF cells and higher expression in EB cells. (B) In situ (miR-21)-immunoﬂuorescence (REST protein) assay showedhigher REST
and lowermiR-21 expression patterns in cells culturedwith LIF (ES) and reversal of this pattern in cells culturedwithout LIF (EB). (C) Forced expression of REST blocksmiR-21 expression
in mESCs cultured in the absence of LIF. In situ immunoﬂuorescence showed that in the absence of LIF pRest transfection blocked miR-21 expression, whereas cells transfected with
pControl showed expression of miR-21. Scale bar, 50 μm.
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either anti-miR-21 or the control anti-egfp, withdrew LIF from the
medium, and analyzed the cells by Western blotting (Fig. 2C) and
double-immunoﬂuorescence (Fig. 2D). As shown, anti-miR-21 treat-
ment maintained the expression of Sox2 at higher levels than the
control treatment. However, the REST expression levels remained
unchanged, conﬁrming the conclusion that miR-21 is downstream of
REST and upstream of Sox2. Thus, taken together, these experiments
indicate that miR-21, regulated by REST, suppresses Sox2 expression.
3.3. miR-21 destabilizes Sox2 mRNA and, thus, decreases self-renewal in
E14Tg2a.4 mESCs
To further determine whether miR-21 regulates Sox2 mechanisti-
cally, we took a more physiologically relevant approach, in which we
measured the impact of miR-21 on the expression of endogenous
Sox2 by measuring expression of the SOX2 protein rather than
employing an assay that only measured reporter gene expression. This
removed any potential differences in the protein stability of the actual
target protein. More importantly, whereas the reporter assay uses the
miR-21 binding site on an artiﬁcial 3′-UTR construct plasmid, removed
from the in vivo context of the surrounding sequences, our assay inter-
rogated the single endogenousmiR-21 binding site in its native second-
ary structure present on the Sox2 3′-UTR.
We transfected precursor miR-21 (pre-miR-21) and its non-
targeting control into E14Tg2a.4 cells, cultured the cells without feeder
cells but in the presence of LIF to maintain self-renewal, and analyzedthe cells. Pre-miR-21 caused an increase in the intracellular miR-21
levels (Fig. 3A), which resulted in lowered rates of self-renewal
(Fig. 3B). To determine whether miR-21 directly affects the expression
of the self-renewal regulators Sox2 and Oct4, we employed Western
blotting methods at various time points after transfection of pre-miR-
21 to determine the protein levels (Fig. 3C). As shown, by 12 h post-
transfection, the exogenous miR-21 ﬁrst caused a substantial decrease
in the Sox2, but not Oct4, protein levels when compared with the con-
trol cells. By this time, the level of Oct4 inmiR-21-treated cells remained
similar to the control cells. By 60 h post-transfection, both Sox2 and
Oct4 protein levels were reduced by 60 h post-transfection, supporting
the idea that these core self-renewal regulators form an interconnected
autoregulatory network (Boyer et al., 2005; Kim et al., 2008; Cole et al.,
2008;Marson et al., 2008), inwhich lowering the level of one eventually
reduces the other. These results showed a hierarchy in the decrease of
Sox2 and Oct4 in response to exogenous pre-miR-21 and suggested
that Sox2 is an immediate target of miR-21 in mESCs.
3.4. Exogenous Sox2 with deleted miR-21 binding site counters the
suppression of self-renewal by miR-21 in mESCs
To conﬁrm that Sox2 is a target of miR-21, we transfected mESCs
with plasmids encoding the puromycin resistance gene and HA-
tagged Sox2 (Maruyama et al., 2005) cDNA that lacked the potential
miR-21 binding site (Fig. 4A). We then selected the puromycin-
resistant cells, transfected them with pre-miR-21 or the non-targeting
control, and determined the intracellular concentration of miR-21
Fig. 2.miR-21 suppresses Sox2 expression in E14Tg2a.4 mESCs. (A) shRNA-mediated knockdown of Rest results in expression of miR-21. In situ-immunoﬂuorescence analysis showed
mutually exclusive expression patterns of miR-21 and REST. shRest-treated cells showed expression of miR-21, whereas non-targeting (NT) transfected cells showed expression of Rest.
Scale bar, 50 μm. (B) shRNA-mediated knockdownof Rest results in higher expression ofmiR-21 and concomitant loss of Sox2 expression. In situ-immunoﬂuorescence analysis of shRest-treat-
ed cells cultured with LIF showed increased levels of miR-21 and decreased levels of Sox2 expression, whereas NT-treated cells showed lower levels of miR-21 and higher levels of Sox2 ex-
pression. Scale bar, 50 μm. (C, D) miR-21 targets Sox2 in mESCs. The presence of anti-miR-21 in differentiating mESCs counters the effect of miR-21 on Sox2 levels. mESCs transfected with
control (anti-sense against egfp; Anti-egfp) or anti-miR-21were cultured in the absence of LIF and analyzed byWestern blotting (C) and double immunoﬂuorescence (D). Anti-miR-21main-
tained the expression of Sox2 at higher levels than the control treatment. However, REST levels remained unchanged. β-actin was used as an internal control (C). Scale bar in (D) is 100 μm.
308 S.K. Singh et al. / Stem Cell Research 15 (2015) 305–311(Fig. 4B) and the cells' self-renewal capacity using alkaline phosphatase
assay (Fig. 4C). As shown, although transfection of exogenous pre-miR-
21 caused an increase in the intracellular miR-21 levels, as expected,Fig. 3.miR-21-Sox2 axis regulates self-renewal in E14Tg2a.4mESCs. (A) Transfection of pre-miR
intracellular miR-21 levels. Relative expression level of miR-21 inmESCs transfected with pre-m
bars are standard error of means (n = 3). *: p-value = b0.001. (B) Pre-miR-21-transfected cel
cells. Percentages of self-renewing colonies were calculated after alkaline phosphatase assa
*: p-value = b0.001. (C) miR-21 ﬁrst reduces Sox2 expression followed by Oct4 expression i
to Western blotting assays performed at two time points post-transfection to determine the ex
levels were the ﬁrst to be lowered compared with Oct4 and Nanog.this manipulation was unable to lower the self-renewal ability of
cells expressing HA-Sox2. This result was in contrast to what was previ-
ously seen in cells without HA-Sox2 (Fig. 3B). We then determined the-21, but not non-targeting control (NT), inmESCs cultured in the presence of LIF increases
iR-21 is shown and is normalized against mESCs transfected with control (pre-NT). Error
ls (described in A) show lower self-renewal efﬁciency compared with pre-NT-transfected
y and are shown for each transfection. Error bars are standard error of means (n = 3).
n mESCs. mESCs transfected with pre-miR-21 or pre-NT (described in A) were subjected
pression levels of Sox2 and Oct4 proteins. β-actin is the loading control. Sox2 expression
Fig. 4. Exogenous Sox2with deletedmiR-21 binding site counters the suppression of self-renewal bymiR-21 inmESCs. Sox2 devoid ofmiR-21 target sequence countersmiR-21-mediated
suppression of self-renewal in E14Tg2a.4 mESCs. (A) Schematic representation of putative miR-21 binding site in the 3′ UTR of the mouse Sox2 gene and truncated HA-tagged sox2
(HA-Sox2). (B) Transfection of pre-miR-21, but not non-targeting control (NT), in mES+ HA-Sox2 increases intracellular miR-21 levels. mESCs expressing exogenous HA-Sox2 with de-
leted miR-21 target sequence were cultured in the presence of LIF and transfected with pre-miR-21 or with pre-NT. Quantitative RT-PCR shows transfection with pre-miR-21, compared
with NT, caused an increase in intracellular miR-21. Error bars are standard error ofmeans (n= 3). *: p-value= b0.001. (C) Expression of HA-sox2 inmESCs nulliﬁes the effect of miR-21
on self-renewal. Percentages of self-renewing colonies were calculated after alkaline phosphatase assay and are shown for each transfection. Each value was normalized to an internal
control (GAPDH) and 0 h time point. Error bars are standard error of means (n = 3). (D) Transfection with pre-miR-21 in ES cells expressing HA-Sox2 fails to lower total Sox2 and
Oct4 protein levels. Western blot analysis was performed for mES + HA-Sox2 cells grown in the presence of LIF and transfected with pre-NT and pre-miR-21. Antibodies against Sox2,
HA, and OCT4 were used. Transfection with pre-miR-21, compared with pre-NT, lowered the protein levels of the endogenous Sox2 (Sox2), which contains the potential miR-21 target
site, but not HA-Sox2, or Oct4. β-actin is an internal control. (E) Working model describing maintenance factors versus core factors in self-renewal of mESCs. Our published (Singh et
al., 2008) as well as unpublished results suggest that phosphorylated STAT3 (P-STAT3), known to be generated by LIF, directly activates Rest gene transcription. REST represses miR-
21, which suppresses Sox2 expression. Sox2, Nanog, and Oct4 form an autoregulatory loop (Boyer et al., 2005; Kim et al., 2008; Cole et al., 2008; Marson et al., 2008). Broken arrow rep-
resents promoter occupancy of core pluripotency factors on the Rest gene (Kim et al., 2008; Marson et al., 2008). Solid arrows represent Nanog–REST protein–protein interaction (Kim
et al., 2008;Wang et al., 2006). Feeder cells or extracellularmatrix components, such as laminin, can counter REST-mediated regulation of mESC pluripotency by suppressing the pathway
or by activating the core factors.
309S.K. Singh et al. / Stem Cell Research 15 (2015) 305–311protein levels of Sox2, HA-Sox2 and Oct4 in these cells. As shown, the
endogenous Sox2 level was lower in miR-21-treated compared with
control-treated cells, as expected (Fig. 4D). However, HA-Sox2, with
the deleted miR-21 binding site, and Oct4 protein levels remained sim-
ilar in miR-21- versus control-treated cells, suggesting that the exoge-
nous HA-Sox2 helped maintain self-renewal and the corresponding
Oct4 levels. Thus, these results gave strong evidence of direct destabili-
zation of chromosomally-expressed Sox2 by miR-21. Taken together,these experiments indicate that the REST–miR-21–Sox2 axis regulates
self-renewal in E14Tg2a.4 mESCs.
4. Discussion
Here, we propose that under permissive conditions, miR-21 sup-
presses Sox2 expression and the REST–miR-21–Sox2 axis regulates
self-renewal and pluripotency in E14Tg2a.4 mESCs. The suppressive
310 S.K. Singh et al. / Stem Cell Research 15 (2015) 305–311effect of miR-21 has been recently seen in other cell types (Trohatou
et al., 2014; Ni et al., 2014). Because pluripotency is a critical decision-
making step for mESCs, one would expect that several counteracting
mechanisms would modulate it so that the mESC pluripotency is main-
tained in equilibrium with environmental cues. We suggest that while
Oct4, Sox2, and Nanog serve as core pluripotency factors, REST and
miR-21 serve asmaintenance factors in themESC pluripotency network
(Fig. 4E). This classiﬁcation is based on the impact of these factors on the
normal development of blastocysts (Supplementary Fig. S2). Mice
haploinsufﬁcient in either the core ormaintenance factors are apparent-
ly normal. However, the distinction between the core and maintenance
factors becomes apparent in null mice. Mouse embryos deﬁcient in the
core self-renewal regulators (Oct4−/−, Nanog−/−, and Sox2−/−) are im-
mediately affected; these embryos develop to the blastocyst stage but
fail to develop further under normal conditions (Avilion et al., 2003;
Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 1998). In con-
trast, mouse embryos deﬁcient in maintenance factors show an appar-
ent lack of an immediate effect on blastocyst development. Rest (−/−
)mice survive past the blastocyst stage but showprogressive embryonic
lethality between embryonic days 9.5 and 11 (Chen et al., 1998), and
miR-21−/−mice are phenotypically normal (Ma et al., 2011). This sce-
nario is very similar to the other maintenance factors, LIF, Stat3 and
Myc. LIF−/−mice are viable and show only retarded postnatal growth
(Stewart et al., 1992), LIFRβ−/− mice die only after birth (Li et al.,
1995), gp130−/− mice die between 12.5 days postcoitum and term
(Nichols et al., 2001), Stat3−/− embryos develop until embryonic day
6 and then degenerate between embryonic days 6.5 and 7.5 (Takeda
et al., 1997), c-Myc−/− mice develop until embryonic day 10.5 (Davis
et al., 1993). These results indicate that the maintenance factors are
not needed for the regulation of blastocyst development under normal
conditions. Our results suggest that loss of these maintenance factors
can be compensated for by other known, or unknown, factors in the net-
work, including extracellular cues providedby feeder cells or extracellu-
lar matrix components such as laminin (Singh et al., 2012).
Why themaintenance factors are not essential for normal blastocyst
development is unclear. One possibility is that under normal conditions,
the inner cellmass is transient, so that even the complete absence of any
of these factors does not produce the full detrimental effect. However, if
the inner cell mass cells were subjected to a slowed or prolonged
growth period, a situation similar to mESC culture in vitro, then the de-
ﬁciency of these factors would result in the developmental arrest of
blastocysts. This hypothesis is supported by the ﬁnding that gp130−/−
blastocysts were arrested only when they were subjected to diapause,
a phenomenon of delayed blastocyst development that has evolved
in some mammals, including mice, to get around adverse conditions
during pregnancy (Nichols et al., 2001).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.05.003.
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